MX336896B - Formulaciones adecuadas para la generacion de imagenes pet con agentes pet hidrofobicos. - Google Patents

Formulaciones adecuadas para la generacion de imagenes pet con agentes pet hidrofobicos.

Info

Publication number
MX336896B
MX336896B MX2012007431A MX2012007431A MX336896B MX 336896 B MX336896 B MX 336896B MX 2012007431 A MX2012007431 A MX 2012007431A MX 2012007431 A MX2012007431 A MX 2012007431A MX 336896 B MX336896 B MX 336896B
Authority
MX
Mexico
Prior art keywords
pet
formulations suitable
hydrophobic
agents
imaging
Prior art date
Application number
MX2012007431A
Other languages
English (en)
Other versions
MX2012007431A (es
Inventor
Michael Krause
Carsten Olbrich
Andreas Burkhard
Original Assignee
Piramal Imaging Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Imaging Sa filed Critical Piramal Imaging Sa
Publication of MX2012007431A publication Critical patent/MX2012007431A/es
Publication of MX336896B publication Critical patent/MX336896B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Formulaciones de derivados basados en el ligando beta amiloide lipofílico de estilbeno y más particularmente formulaciones que se pueden administrar por vía parental, por ejemplo intravenosa, en donde el derivado basado en el ligando beta amiloide lipofílico estilbeno es un radiofármaco marcado con 19F o 18F del mismo. Además, la invención está dirigida a un método de filtración estéril de dicha formulación adecuada.
MX2012007431A 2009-12-23 2010-12-22 Formulaciones adecuadas para la generacion de imagenes pet con agentes pet hidrofobicos. MX336896B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09075568 2009-12-23
PCT/EP2010/070455 WO2011076825A1 (en) 2009-12-23 2010-12-22 Formulations suitable for pet imaging with hydrophobic pet agents

Publications (2)

Publication Number Publication Date
MX2012007431A MX2012007431A (es) 2012-10-15
MX336896B true MX336896B (es) 2016-02-05

Family

ID=43797709

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007431A MX336896B (es) 2009-12-23 2010-12-22 Formulaciones adecuadas para la generacion de imagenes pet con agentes pet hidrofobicos.

Country Status (18)

Country Link
US (1) US20120328521A1 (es)
EP (1) EP2515948A1 (es)
JP (1) JP5774023B2 (es)
KR (1) KR20120098914A (es)
CN (1) CN102762229B9 (es)
AR (1) AR079687A1 (es)
AU (1) AU2010334929B2 (es)
BR (1) BR112012015369A2 (es)
CA (1) CA2785576C (es)
EA (1) EA022447B1 (es)
HK (1) HK1178064A1 (es)
IL (1) IL220569A0 (es)
MX (1) MX336896B (es)
SG (1) SG181903A1 (es)
TW (1) TW201138833A (es)
UY (1) UY33152A (es)
WO (1) WO2011076825A1 (es)
ZA (1) ZA201204683B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013126898A1 (en) * 2012-02-24 2013-08-29 Case Western Reserve University Molecular probes for detecting lipids
RU2623867C2 (ru) * 2011-06-21 2017-06-29 Пирамаль Имэджинг Са Композиции фторированного стильбена, пригодные для пэт визуализации
JP6207588B2 (ja) * 2012-04-10 2017-10-04 ランセウス メディカル イメージング， インコーポレイテッド 放射性薬剤合成方法
US10765763B2 (en) 2016-03-09 2020-09-08 Case Western Reserve University Radioligands for myelin
TW201906818A (zh) * 2017-05-31 2019-02-16 美商５１１製藥公司 新穎氘取代之正子發射斷層掃描（ｐｅｔ）顯影劑及其藥理應用
WO2019145293A1 (en) * 2018-01-24 2019-08-01 Ac Immune Sa Diagnostic compositions for pet imaging, a method for manufacturing the diagnostic composition and its use in diagnostics
WO2020202831A1 (ja) * 2019-03-29 2020-10-08 国立研究開発法人量子科学技術研究開発機構 放射性医薬の製造方法及び放射性医薬

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11505526A (ja) * 1995-05-01 1999-05-21 ユニヴァーシティ・オヴ・ピッツバーグ アルツハイマー病の死前診断ならびにアミロイド沈着のイン・ビボのイメージ化及び予防のためのアゾ化合物
DE10012120A1 (de) * 2000-03-13 2001-09-27 Ktb Tumorforschungs Gmbh Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel
JP2004536026A (ja) * 2000-11-28 2004-12-02 トランスフォーム ファーマシューティカルズ，インコーポレーティッド． パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
JP4436928B2 (ja) * 2001-08-27 2010-03-24 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア スチルベン誘導体、およびアミロイド斑の結合および画像化のためのその使用
CA2463902A1 (en) * 2001-10-26 2003-05-01 Oxigene, Inc. Functionalized stilbene derivatives as improved vascular targeting agents
CN101123995B (zh) * 2004-12-17 2011-11-16 宾夕法尼亚大学理事会 茋衍生物及其用于结合和成像淀粉样蛋白斑的用途
SI2213652T1 (sl) 2004-12-17 2015-03-31 The Trustees Of The University Of Pennsylvania Derivati stilbena in njihova uporaba za vezavo in prikaz amiloidnih plakov
PL2363392T3 (pl) * 2006-03-30 2017-10-31 Univ Pennsylvania Styrylopirydynowe pochodne i ich zastosowanie do wiązania i obrazowania płytek amyloidowych
EP2214722A1 (en) * 2007-11-07 2010-08-11 GE Healthcare BV Stabilization of radiopharmaceuticals
US20100310456A1 (en) * 2009-06-04 2010-12-09 General Electric Company Imaging of myelin basic protein

Also Published As

Publication number Publication date
US20120328521A1 (en) 2012-12-27
TW201138833A (en) 2011-11-16
IL220569A0 (en) 2012-08-30
SG181903A1 (en) 2012-07-30
CA2785576C (en) 2017-12-05
AU2010334929A1 (en) 2012-07-05
KR20120098914A (ko) 2012-09-05
CN102762229B (zh) 2014-11-12
MX2012007431A (es) 2012-10-15
AR079687A1 (es) 2012-02-15
CN102762229B9 (zh) 2020-12-01
BR112012015369A2 (pt) 2018-01-23
ZA201204683B (en) 2013-04-24
EA201200940A1 (ru) 2013-02-28
WO2011076825A1 (en) 2011-06-30
CA2785576A1 (en) 2011-06-30
JP5774023B2 (ja) 2015-09-02
JP2013515694A (ja) 2013-05-09
EP2515948A1 (en) 2012-10-31
UY33152A (es) 2011-07-29
CN102762229A (zh) 2012-10-31
EA022447B1 (ru) 2016-01-29
HK1178064A1 (en) 2013-09-06
AU2010334929B2 (en) 2015-04-23

Similar Documents

Publication Publication Date Title
MX336896B (es) Formulaciones adecuadas para la generacion de imagenes pet con agentes pet hidrofobicos.
CL2012002896A1 (es) Compuestos para tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide; composicion farmacéutica que lo comprende; uso del compuesto para retener o incrementar la memoria cognitiva.
DK2202216T3 (da) Spiro-ringforbindelse samt dens anvendelse til medicinske formål
EP2435815A4 (en) OPTICAL COHERENCE TOMOGRAPHY FOR BIOLOGICAL IMAGING
SMT201600040B (it) Rilascio non covalente peptide-mediato di agenti attivi attraverso la barriera emato-encefalica
HK1173043A1 (en) Meso-sized capsules useful for the delivery of agricultural chemicals
RS58104B1 (sr) Farmaceutske kombinacije za lečenje alchajmerove bolesti
FR2972915B1 (fr) Systeme d'imagerie medicale multiplan
IL222897A (en) Preparations, compounds and methods for the synthesis and use of imaging agents
MX2017004695A (es) Formación de imágenes por irm de placas amiloides usando liposomas.
ECSP12012290A (es) Formulaciones farmacéuticas
CL2014002756A1 (es) Compuestos derivados de 1,4-benzotiazepina; composición farmacéutica que lo comprende; uso para tratar afecciones relacionadas con función anormal de receptores de rianodina; y método de preparación del compuesto.
FR2966343B1 (fr) Jeu de composants glenoidiens d'une prothese d'epaule
IL207853A0 (en) Contrast agents for applications including perfusion imaging
EP2788034A4 (en) SPECTRAL IMAGING RADIOMETRY FOR EARLY DETECTION OF ALZHEIMER'S DISEASE
PT2552449T (pt) Composições que compreendem brimonidina para o tratamento de eritema
GB201112246D0 (en) Diagnosis of alzheimer's disease
EA201890221A1 (ru) Hbed-бисфосфонаты, их конъюгаты с радиометаллом и их применение в качестве лечебно-диагностических агентов
HK1206343A1 (zh) 可用作阿爾茨海默病的診斷劑的咪唑並 噻唑- -酮衍生物
CU24028B1 (es) Proceso para obtener micropartículas mejoradas que comprenden un derivado de somatostatina
CL2015001881A1 (es) Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición.
CL2008001503A1 (es) Compuestos derivados de azaciclilbenzamidas, antagonistas de histamina-3; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para tratar un trastorno neurodegenerativo, como alzheimer, parkinso
WO2008026040A3 (en) 68ga-labeled peptide-based radiopharmaceuticals
BR112015032262A2 (pt) composições de nanopartículas e formulações de compostos de piperazina
GB0920839D0 (en) Contrast agents for medical imaging

Legal Events

Date Code Title Description
FG Grant or registration